Logo image of ZFGN

Zafgen Inc (ZFGN) Stock Price, Quote, News and Overview

NASDAQ:ZFGN - Nasdaq -

0.99  -0.17 (-14.66%)

After market: 0.97 -0.02 (-2.02%)

ZFGN Quote, Performance and Key Statistics

Zafgen Inc

NASDAQ:ZFGN (5/28/2020, 8:00:10 PM)

After market: 0.97 -0.02 (-2.02%)

0.99

-0.17 (-14.66%)

Sector
GICS SectorN/A
GICS IndustryN/A
GICS IndustryGroupN/A
GICS SubIndustryN/A
Statistics
52 Week High1.88
52 Week Low0.62
Market Cap37.10M
Shares37.47M
Float12.17M
Yearly DividendN/A
Dividend YieldN/A
PEN/A
Fwd PEN/A
Earnings (Next)N/A N/A
IPON/A N/A


ZFGN short term performance overview.The bars show the price performance of ZFGN in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 10 -10 20

ZFGN long term performance overview.The bars show the price performance of ZFGN in the last 1, 2 and 3 years. 1 year 2 years 3 years -10 -20 -30 -40

The current stock price of ZFGN is 0.99 null. In the past month the price increased by 26.16%. In the past year, price decreased by -45.9%.

Zafgen Inc / ZFGN Daily stock chart

About ZFGN

Company Profile

Zafgen, Inc. is a biopharmaceutical company. The Company develops therapeutics for patients suffering from obesity and obesity-related disorders. Its lead product candidate includes Beloranib, an injection that is in Phase II clinical trials for the treatment of various indications comprising obesity and hyperphagia in Prader-Willi Syndrome patients, craniopharyngioma-associated obesity, and severe obesity in the general population. Zafgen, Inc. is headquartered in Cambridge, Massachusetts.

Company Info

Zafgen Inc

3 Center Plaza Suite 610

BOSTON MA 02108

CEO: Jeffrey Hatfield

Phone: 617-622-4003

Zafgen Inc / ZFGN FAQ

What is the stock price of Zafgen Inc today?

The current stock price of ZFGN is 0.99 null. The price decreased by -14.66% in the last trading session.


What is the ticker symbol for Zafgen Inc stock?

The exchange symbol of Zafgen Inc is ZFGN and it is listed on the Nasdaq exchange.


On which exchange is ZFGN stock listed?

ZFGN stock is listed on the Nasdaq exchange.


What is Zafgen Inc worth?

Zafgen Inc (ZFGN) has a market capitalization of 37.10M null. This makes ZFGN a Nano Cap stock.


What are the support and resistance levels for Zafgen Inc (ZFGN) stock?

Zafgen Inc (ZFGN) has a support level at 0.84 and a resistance level at 1.1. Check the full technical report for a detailed analysis of ZFGN support and resistance levels.


Should I buy Zafgen Inc (ZFGN) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does Zafgen Inc (ZFGN) stock pay dividends?

ZFGN does not pay a dividend.


What is the Price/Earnings (PE) ratio of Zafgen Inc (ZFGN)?

Zafgen Inc (ZFGN) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.81).


ZFGN Technical Analysis

ChartMill assigns a technical rating of 5 / 10 to ZFGN. When comparing the yearly performance of all stocks, ZFGN is a bad performer in the overall market: 88.88% of all stocks are doing better.


Chartmill TA Rating
Chartmill Setup Rating

ZFGN Fundamental Analysis

ChartMill assigns a fundamental rating of 2 / 10 to ZFGN. ZFGN may be in some trouble as it scores bad on both profitability and health.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

ZFGN Financial Highlights

Over the last trailing twelve months ZFGN reported a non-GAAP Earnings per Share(EPS) of -0.81. The EPS increased by 52.91% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -48.7%
ROE N/A
Debt/Equity 0.26
Chartmill High Growth Momentum
EPS Q2Q%71.43%
Sales Q2Q%N/A
EPS 1Y (TTM)52.91%
Revenue 1Y (TTM)N/A

ZFGN Ownership and Analysts

ChartMill assigns a Buy % Consensus number of 60% to ZFGN. The Buy consensus is the average rating of analysts ratings from 2 analysts.


Ownership
Inst Owners70.43%
Ins Owners26.62%
Short Float %N/A
Short RatioN/A
Analysts
Analysts60
Price TargetN/A
EPS Next Y30.84%
Revenue Next YearN/A